Australia's most trusted
source of pharma news
Posted 23 November 2021 AM
Health industry heavyweight and Independent Chair of the Generic and Biosimilars Medicines Association (GBMA) Jane Halton has called for bipartisan support of a 'landmark' bill under debate in federal parliament this week aimed at protecting Australia against ongoing medicines shortages.
The National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Bill 2021 is enabling legislation for the Strategic Agreement between government and industry which will see generic companies significantly increasing their stock holdings of medicines in country to four to six months.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.